An interventional study of EXORA block 15 and EXORA block 25 in Pain, Postoperative and Post Operative Analgesia, sponsored by Fayoum University Hospital. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-02.
Sponsored by Fayoum University Hospital · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Pain, Postoperative by Fayoum University Hospital — 4 open to participants now, 4 under way, none of them phase 3. Pain, Postoperative · Fayoum University Hospital.
Among the 17 studies in Pain, Postoperative by Fayoum University Hospital, this one is the 5th largest by planned enrollment, is one of 3 that started in 2026, is one of 14 with no phase, and was the 16th registered.
5,675 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →4 of the 17 studies in Pain, Postoperative by Fayoum University Hospital are open now, in 2 countries. Recruiting first, the newest first:
Fayoum University Hospital · Sites in Egypt
Ages 18–65
Fayoum University Hospital · Sites in Egypt
Ages 50–90
Fayoum University Hospital · Sites in Saudi Arabia
Ages 20–65
By country, each count listing its studies:
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 96 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 66 across the 17 interventional studies. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Fayoum University Hospital is the lead sponsor of 77 studies on the registry; 14 are open to participants now.
3 of the studies in Pain, Postoperative by Fayoum University Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07507799Fayoum University HospitalLow Versus Standard Volume EXORA Block in Laparoscopic Cholecystectomy | 2027-01-01 |
| NCT07556536Fayoum University HospitalComparison of Serratus Intercostal Plane Blcok With Erector Spinae Plane Block for Open Nephrectomy | 2027-03-01 |
| NCT07442721Fayoum University HospitalSacral ESPB vs. PENG Block for Hip Hemiarthroplasty Analgesia | 2027-07-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 17 studies in Pain, Postoperative by Fayoum University Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The original EXORA block used high local anesthetic volume (50 mL total), raising concerns about local anesthetic systemic toxicity (LAST). In such a bilaterally administered regional technique, evaluating the efficacy of a reduced-volume approach is warranted to maximize patient safety.
Study Design \& Population This is a prospective, randomized, double-blinded trial enrolling patients scheduled for elective laparoscopic cholecystectomy. Following informed consent, patients will be randomly allocated into two equal groups to evaluate different volumes used in a bilateral, ultrasound-guided External Oblique and Rectus Abdominis (EXORA) block.
Interventions Prior to the induction of general anesthesia, patients will receive a bilateral EXORA block using 0.25% bupivacaine.
Group E15: Will receive 15 mL of the local anesthetic on each side. Group E25: Will receive 25 mL of the local anesthetic on each side. Blinding \& Allocation Allocation concealment will be maintained using sequentially numbered, opaque, sealed envelopes. The block will be performed by a designated regional anesthesiologist who will not be involved in subsequent patient care. The patient, the surgical team, the intraoperative anesthesiologist, and the postoperative data collectors will remain strictly blinded to the group allocation and the volume injected.
Anesthesia \& Perioperative Management Sensory block distribution will be assessed prior to surgery. All patients will receive a standardized general anesthesia protocol for induction and maintenance. Intraoperative hemodynamics will be managed according to standard institutional protocols.
Postoperative Analgesia \& Monitoring Upon transfer to the Post-Anesthesia Care Unit (PACU) and throughout the first 24 hours, all patients will receive scheduled, standardized multimodal analgesia (intravenous paracetamol and ketorolac). Postoperative pain will be assessed using the 11-point Numerical Rating Scale (NRS) at rest and during movement at prespecified time points. If the dynamic NRS score is ≥ 4, intravenous morphine (2 mg) will be administered . Patients will be continuously monitored for adverse events, including postoperative nausea and vomiting (PONV), hemodynamic instability, and local anesthetic systemic toxicity (LAST), which will be managed with predefined rescue medications
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patient refusal to participate.
Criteria for Withdrawal from Study Analysis (Drop-outs):
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
15 mL of bupivacaine 0.25% administered bilaterally
Procedure: EXORA block 15
25 mL of bupivacaine 0.25% administered bilaterally
Procedure: EXORA block 25
15 mL of bupivacaine 0.25% administered bilaterally by ultrasound guided EXORA block
25 mL of bupivacaine 0.25% administered bilaterally by ultrasound guided EXORA block
Dynamic numerical rating scale (NRS) score at 4 hours postoperatively.
From 0 to 10 where 0 denote no pain and 10 denote the worst pain ever experienced with cough
Time frame: 4 hours after surgery
Static Numerical Rating scale NRS scores
From 0 to 10 where 0 denote no pain and 10 denote the worst pain ever experienced At predefined time points.(1,2,4,6,12 and 24 hours post operatively
Time frame: up to 24 hours post operatively
Dynamic numerical rating scale NRS scores
From 0 to 10 where 0 denote no pain and 10 denote the worst pain ever experienced With cough at predefined time points.(1,2,6,12 and 24 hours post operatively
Time frame: up to 24 hours post operatively
Cumulative Static Pain Burden
calculated as the Area Under the Curve (AUC) of Static NRS scores over the 24-hour postoperative period
Time frame: Up to 24h postoperatively
Cumulative Dynamic Pain Burden
calculated as the Area Under the Curve (AUC) of Dynamic NRS scores over the 24-hour postoperative period
Time frame: Up to 24h postoperatively
Intraoperative Fentanyl consumption Total fentanyl in micrograms
Total fentanyl in micrograms
Time frame: From induction of anesthesia until patient is transferred to postoperative care unit up to 4 hours]
Total cumulative consumption of intravenous morphine over the first 24 hours.
total morphine used in milligrams post operatively over 24 hours.
Time frame: At 24 hours postoperatively
Time to first rescue analgesia
Time to first request of rescue analgesia in hours
Time frame: Upon recovery from General anesthesia up to 24 hours postoperatively]
Sensory block distribution level (pin-prick test)
After 30 minutes of the block, assessed at. Midclavicular and Midaxillary lines from T5 to T12 level by a blinded anesthesiologist
Time frame: At 30 minuets from the block
Quality of recovery score (QoR-15) at 24 hours.
scores range from 0 to 150, with a higher score indicating a better quality of postoperative recovery.
Time frame: At 24 hours postoperatively
Incidence of adverse events: bradycardia, hypotension, PONV, and LAST.
Assessment of each patient looking for any of adverse effects as bradycardia ,hypotension, nausea, vomiting and LAST.
Time frame: From induction of anesthesia up to 24 hours postoperatively
Heart rate
Heart rate measured at Baseline (T0), 3 minutes post-intubation (T1), 1 minute post-skin incision (T2), 5 minutes after pneumoperitoneum inflation (T3), At extubation (T4) and postoperatively upon arrival in the PACU (0 hours), 1, 2, 4, 6, 12, and 24 hours
Time frame: Upon arrival to Operating Room until 24 hours postoperative
Mean arterial pressure
Mean arterial pressure measured at Baseline (T0), 3 minutes post-intubation (T1), 1 minute post-skin incision (T2), 5 minutes after pneumoperitoneum inflation (T3), At extubation (T4) and postoperatively upon arrival in the PACU (0 hours), 1, 2, 4, 6, 12, and 24 hours
Time frame: Upon arrival to Operating Room until 24 hours postoperative
Ramsay Sedation Scale (RSS)
from 1 to 6 where 1 denotes anxious/agitated and 6 denotes deep sedation with no response to stimuli (6) assessed postoperative (at 1, 2, 4, 6, 12, and 24 hours)
Time frame: up to 24 hours
Plan to share: No
Started Apr 2026 (actual). Primary completion is estimated for Jan 2027, 8 months after the start.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 8 months is below that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fayoum University Hospital